Dare Bioscience Inc reports results for the quarter ended in June - Earnings Summary

Dare Bioscience

09/08/2022 15:11

* Dare Bioscience Inc  DARE.OQ  reported quarterly breakeven
results​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss of 6
cents per share.
    * Revenue was $10.00 million​; analysts expected $10.00
million. 
    * Dare Bioscience Inc's reported EPS for the quarter was
breakeven
results​.
    * The mean earnings estimate of analysts had risen by
about 47.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Dare Bioscience Inc shares had risen by 1.6% this
quarter and
lost 37.5% so far this year.
    * The company reported quarterly net income of $414
thousand.
    * Wall Street's median 12-month price target for Dare
Bioscience
Inc is $5.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 02:11 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.06          0.00           Beat
 Mar. 31 2022      -0.14          -0.10          Beat
 Dec. 31 2021      -0.15          -0.18          Missed
 Sep. 30 2021      -0.13          -0.18          Missed